tiprankstipranks
Blurbs

Analysts Are Bullish on These Healthcare Stocks: Bio-Rad Laboratories (BIO), Tenet Healthcare (THC)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bio-Rad Laboratories (BIOResearch Report), Tenet Healthcare (THCResearch Report) and Immunocore Holdings (IMCRResearch Report) with bullish sentiments.

Bio-Rad Laboratories (BIO)

In a report released yesterday, Brandon Couillard from Jefferies maintained a Buy rating on Bio-Rad Laboratories, with a price target of $780.00. The company’s shares closed last Friday at $582.54, close to its 52-week low of $547.22.

According to TipRanks.com, Couillard is a top 100 analyst with an average return of 26.4% and a 73.7% success rate. Couillard covers the Healthcare sector, focusing on stocks such as Exact Sciences, Align Tech, and Danaher.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bio-Rad Laboratories with a $790.00 average price target.

See the top stocks recommended by analysts >>

Tenet Healthcare (THC)

Jefferies analyst Brian Tanquilut maintained a Buy rating on Tenet Healthcare on March 4 and set a price target of $125.00. The company’s shares closed last Friday at $91.13, close to its 52-week high of $91.89.

According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 6.1% and a 55.7% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Privia Health Group, and AmerisourceBergen.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tenet Healthcare with a $104.50 average price target, a 17.1% upside from current levels. In a report issued on March 1, Goldman Sachs also initiated coverage with a Buy rating on the stock with a $121.00 price target.

Immunocore Holdings (IMCR)

Jefferies analyst Michael Yee maintained a Buy rating on Immunocore Holdings yesterday and set a price target of $45.00. The company’s shares closed last Friday at $22.40, close to its 52-week low of $18.43.

According to TipRanks.com, Yee is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -4.0% and a 39.5% success rate. Yee covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Olema Pharmaceuticals, and Scholar Rock Holding.

Currently, the analyst consensus on Immunocore Holdings is a Moderate Buy with an average price target of $62.50, representing a 178.0% upside. In a report issued on March 4, H.C. Wainwright also maintained a Buy rating on the stock with a $80.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BIO:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed